2024

1. Beaver tail liver

   Gastroenterologia y Hepatologia, Vol. 47, Núm. 8, pp. 873-875

2. Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure

   Digestive and Liver Disease, Vol. 56, Núm. 10, pp. 1721-1729

3. Clinical outcomes of anti-reflux mucosal ablation for gastroesophageal reflux disease: An international bi-institutional study

   Journal of Gastroenterology and Hepatology (Australia), Vol. 39, Núm. 1, pp. 149-156

4. Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis

   Gut, Vol. 73, Núm. 7, pp. 1183-1198

5. Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU

   Therapeutic Advances in Gastroenterology, Vol. 17

6. Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis

   JHEP Reports, Vol. 6, Núm. 2

7. Evolving portal hypertension through Baveno VII recommendations

   Annals of Hepatology, Vol. 29, Núm. 1

8. Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements

   Hepatology, Vol. 79, Núm. 4, pp. 869-881

9. Harnessing the Anti-Inflammatory Properties of Polyphenols in the Treatment of Inflammatory Bowel Disease

   International Journal of Biological Sciences, Vol. 20, Núm. 14, pp. 5608-5672

10. Hepatic cystadenoma as cause of secondary Budd-Chiari syndrome

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 2, pp. 179-180

11. Improving understanding of ferroptosis: Molecular mechanisms, connection with cellular senescence and implications for aging

    Heliyon, Vol. 10, Núm. 21

12. La especialidad de aparato digestivo: historia, desarrollo nacional y competencias del especialista, perspectiva futura

    RIECS: Revista de Investigación y Educación en Ciencias de la Salud, Vol. 9, Núm. 1, pp. 16-24

13. Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice

    Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 12, pp. 1604-1615

14. Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors

    Journal of Hepatology, Vol. 80, Núm. 6, pp. 904-912

15. One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population

    United European Gastroenterology Journal, Vol. 12, Núm. 7, pp. 919-929

16. Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies

    The Lancet Gastroenterology and Hepatology, Vol. 9, Núm. 9, pp. 859-883

17. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome

    Journal of Hepatology

18. Portosinusoidal vascular disorder: A paradigm shift

    Medicina Clinica, Vol. 162, Núm. 9, pp. 439-447

19. Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis

    Hepatology, Vol. 79, Núm. 3, pp. 624-635

20. Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding

    Journal of Hepatology, Vol. 80, Núm. 1, pp. 73-81